Competency information
Details
Analyse and interpret appropriate genetic investigations for the monitoring of patients (eg AML)
Considerations
- Requirements of the sample for successful monitoring of residual disease
- Health and safety requirements for processing fresh samples
- Principles of the techniques for monitoring residual disease
- Choice of appropriate monitoring approaches for different patients
- Limitations of each procedure including limit of detection, sensitivity and specificity
- Factors affecting quality of molecular results Interpretation of results
- National and international guidelines for monitoring of residual disease
- Clinical and therapy relevance of monitoring results
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 3 | Outcome Apply the appropriate testing strategy for a range of complex myeloid malignancies including AML, MDS, considering the approach for subclassification and prognosis of disease |
| # 4 | Outcome Implement the appropriate strategy for monitoring residual disease in patients with acute myeloid leukaemia |